BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15599310)

  • 1. Gene therapy-mediated CD40L and CD28 co-stimulatory signaling blockade plus transient anti-xenograft antibody suppression induces long-term acceptance of cardiac xenografts.
    Hua N; Yamashita K; Hashimoto T; Masunaga T; Fujita M; Furukawa H; Uede T; Todo S
    Transplantation; 2004 Nov; 78(10):1463-70. PubMed ID: 15599310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies.
    Yamashita K; Masunaga T; Yanagida N; Takehara M; Hashimoto T; Kobayashi T; Echizenya H; Hua N; Fujita M; Murakami M; Furukawa H; Uede T; Todo S
    Transplantation; 2003 Oct; 76(7):1089-96. PubMed ID: 14557758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-stimulatory molecules in islet xenotransplantation: CTLA4Ig treatment in CD40 ligand-deficient mice.
    Benda B; Ljunggren HG; Peach R; Sandberg JO; Korsgren O
    Cell Transplant; 2002; 11(7):715-20. PubMed ID: 12518898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of regulatory cells and control of cellular but not vascular rejection by costimulation blockade in hamster-to-rat heart xenotransplantation.
    Séveno C; Coulon F; Haspot F; Mérieau E; Renaudin K; Martinet B; Vanhove B
    Xenotransplantation; 2007 Jan; 14(1):25-33. PubMed ID: 17214702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model.
    Kanaya K; Tsuchida Y; Inobe M; Murakami M; Hirose T; Kon S; Kawaguchi S; Wada T; Yamashita T; Ishii S; Uede T
    Transplantation; 2003 Feb; 75(3):275-81. PubMed ID: 12589145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats.
    Yin DP; Sankary HN; Chong AS; Blinder L; Ma LL; Williams JW
    Transplantation; 1997 Jul; 64(2):317-21. PubMed ID: 9256194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific.
    Chong AS; Ma LL; Yin D; Blinder L; Shen J; Williams JW
    Xenotransplantation; 2000 Feb; 7(1):48-57. PubMed ID: 10809057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicistronic adenovirus-mediated gene transfer of CTLA4Ig gene and CD40Ig gene result in indefinite survival of islet xenograft.
    Jin YZ; Xie SS
    Transplant Proc; 2003 Dec; 35(8):3165-6. PubMed ID: 14698004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not prevent chronic rejection.
    Guillot C; Guillonneau C; Mathieu P; Gerdes CA; Ménoret S; Braudeau C; Tesson L; Renaudin K; Castro MG; Löwenstein PR; Anegon I
    J Immunol; 2002 Feb; 168(4):1600-9. PubMed ID: 11823487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous administration of a low-dose mixture of donor bone marrow cells and splenocytes plus adenovirus containing the CTLA4Ig gene result in stable mixed chimerism and long-term survival of cardiac allograft in rats.
    Jin Y; Zhang Q; Hao J; Gao X; Guo Y; Xie S
    Immunology; 2003 Oct; 110(2):275-86. PubMed ID: 14511242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the CD28 and CD40 pathways result in the acceptance of pig and rat islet xenografts but not rat cardiac grafts in mice.
    Lehnert AM; Mottram PL; Han W; Walters SN; Patel AT; Hawthorne WJ; Cowan PJ; d'Apice AJ; O'Connell PJ
    Transpl Immunol; 2001 Oct; 9(1):51-6. PubMed ID: 11680572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression.
    Potiron N; Chagneau C; Boeffard F; Soulillou JP; Anegon I; Le Mauff B
    Cell Transplant; 2005; 14(5):263-75. PubMed ID: 16052908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated CTLA4 immunoglobulin G gene therapy in cardiac xenotransplantation.
    Watanabe T; Miyatake T; Kumamoto H; Mafune N; Kubota S; Okamoto H; Murashita T; Uede T; Yasuda K
    Transplant Proc; 2004 Oct; 36(8):2478-9. PubMed ID: 15561287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged allograft survival but no tolerance induction by modulating CD28 antibody JJ319 after high-responder rat heart transplantation.
    Dengler TJ; Szabo G; Sido B; Nottmeyer W; Zimmerman R; Vahl CF; Hünig T; Meuer SC
    Transplantation; 1999 Feb; 67(3):392-8. PubMed ID: 10030284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice.
    Yin D; Ma L; Shen J; Byrne GW; Logan JS; Chong AS
    Am J Transplant; 2002 Jan; 2(1):41-7. PubMed ID: 12095055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of donor-specific tolerance by adenovirus-mediated CD40Ig gene therapy in rat liver transplantation.
    Nomura M; Yamashita K; Murakami M; Takehara M; Echizenya H; Sunahara M; Kitagawa N; Fujita M; Furukawa H; Uede T; Todo S
    Transplantation; 2002 May; 73(9):1403-10. PubMed ID: 12023617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.